Journal of Shanghai Jiao Tong University (Medical Science) >

2022 , Vol. 42 >Issue 11: 1542 - 1549

DOI: https://doi.org/10.3969/j.issn.1674-8115.2022.11.004

Basic research

Anticancer effect of drug-loaded DNA nanoflowers on mouse lung cancer cells

  • Hongjian LIAO ,
  • Yuchao CAO ,
  • Yonghong DU
Expand
  • State Key Laboratory of Ultrasound in Medicine and Engineering, College of Biomedical Engineering, Chongqing Medical University; Chongqing Key Laboratory of Biomedical Engineering, Chongqing Medical University, Chongqing 400016, China
DU Yonghong, E-mail: duyonghong@cqmu.edu.cn.

Received date: 2022-07-27

  Accepted date: 2022-10-18

  Online published: 2023-01-04

Supported by

General Program of Technology Innovation and Application Development of Chongqing(cstc2019jscx-msxmX0255)

Fold

Abstract

Objective ·To investigate the anti-cancer effects of DNA nanoflowers (DF) loaded with horseradish peroxidase (HRP) and doxorubicin (DOX) on mice Lewis lung carcinoma (LLC) cells. Methods ·The DF loaded with HRP (HRP-DF) was synthesized by rolling circle amplification (RCA) reaction and DOX was loaded to prepare DOX/HRP-DF, the physical properties of which were detected by scanning electron microscopy and laser particle sizer. In vitro drug release capacity of DOX/HRP-DF was tested with acid buffer solution. The safety of DOX/HRP-DF was evaluated by CCK-8 assay to detect the cytotoxicity of 16HBE cells treated with DOX/HRP-DF and free DOX at different time points. Under anoxic conditions, the oxygen production capacity of DOX/HRP-DF in LLC cells was detected by using the oxygen-sensitive probe, and the effects of different dosages of free DOX, DOX-DF and DOX/HRP-DF on the proliferation capacity of LLC cells were examined by CCK-8 assay. The effects of DOX/HRP-DF on the migration and invasion of LLC cells were detected by scratching assay and Transwell assay in the experimental group treated with different dosages of DOX/HRP-DF and the control group treated with Phosphate Buffered Saline (PBS). Results ·DOX/HRP-DF were successfully prepared and observed as flower-like structures under scanning electron microscopy with uniform size. The average diameter and potential of DOX/HRP-DF were (415.90±9.32) nm and (-17.43±1.20) mV, respectively. DOX/HRP-DF had a DOX loading of (38.19±0.39)% with good pH-sensitive drug release properties. DOX/HRP-DF could significantly reduce the toxic effect of DOX on human normal cells. The results of Laser confocal microscopy showed that DOX/HRP-DF could effectively alleviate the hypoxic condition of LLC cells. CCK-8 assay results showed that the proliferation rate of LLC cells in the DOX/HRP-DF group was significantly lower in a dose-dependent manner, compared to the free DOX and DOX-DF groups (P<0.05). The results of scratching assay showed that the scratch healing rate of the DOX/HRP-DF group was lower than that of PBS group in a dose-dependent manner (P<0.05). Transwell experiments showed the number of LLC cells passing through Matrigel gel in the DOX/HRP-DF group was reduced in a dose-dependent manner, compared with the PBS group (P<0.05). Conclusion ·The successfully prepared DOX/HRP-DF could effectively deliver drugs, and alleviate hypoxia in the tumor microenvironment, and significantly inhibit the proliferation, migration and invasion ability of LLC cells, which is expected to provide new ideas for lung cancer treatment.

Key words： DNA nanoflower (DF); lung cancer; tumor inhibition; hypoxia

Cite this article

Hongjian LIAO , Yuchao CAO , Yonghong DU . Anticancer effect of drug-loaded DNA nanoflowers on mouse lung cancer cells[J]. Journal of Shanghai Jiao Tong University (Medical Science), 2022 , 42(11) : 1542 -1549 . DOI: 10.3969/j.issn.1674-8115.2022.11.004

References

1 WOOD S L, PERNEMALM M, CROSBIE P A, et al. The role of the tumor-microenvironment in lung cancer-metastasis and its relationship to potential therapeutic targets[J]. Cancer Treat Rev, 2014, 40(4): 558-566.
2 LUO R J, LI Y, HE M, et al. Distinct biodistribution of doxorubicin and the altered dispositions mediated by different liposomal formulations[J]. Int J Pharm, 2017, 519(1/2): 1-10.
3 HERBST R S, MORGENSZTERN D, BOSHOFF C. The biology and management of non-small cell lung cancer[J]. Nature, 2018, 553(7689): 446-454.
4 SHENDE P, KASTURE P, GAUD R S. Nanoflowers: the future trend of nanotechnology for multi-applications[J]. Artif Cells Nanomed Biotechnol, 2018, 46(sup1): 413-422.
5 MEI L, ZHU G Z, QIU L P, et al. Self-assembled multifunctional DNA nanoflowers for the circumvention of multidrug resistance in targeted anticancer drug delivery[J]. Nano Res, 2015, 8(11): 3447-3460.
6 MICHIELS C, TELLIER C, FERON O. Cycling hypoxia: a key feature of the tumor microenvironment[J]. Biochim Biophys Acta, 2016, 1866(1): 76-86.
7 NAKAZAWA M S, KEITH B, SIMON M C. Oxygen availability and metabolic adaptations[J]. Nat Rev Cancer, 2016, 16(10): 663-673.
8 JAHANBAN-ESFAHLAN R, DE LA GUARDIA M, AHMADI D, et al. Modulating tumor hypoxia by nanomedicine for effective cancer therapy[J]. J Cell Physiol, 2018, 233(3): 2019-2031.
9 CHEN Q, LIANG C, SUN X Q, et al. H2O2-responsive liposomal nanoprobe for photoacoustic inflammation imaging and tumor theranostics via in vivo chromogenic assay[J]. Proc Natl Acad Sci USA, 2017, 114(21): 5343-5348.
10 GHOSH S, JAVIA A, SHETTY S, et al. Triple negative breast cancer and non-small cell lung cancer: clinical challenges and nano-formulation approaches[J]. J Control Release, 2021, 337: 27-58.
11 DHIMAN N, AWASTHI R, SHARMA B, et al. Lipid nanoparticles as carriers for bioactive delivery[J]. Front Chem, 2021, 9: 580118.
12 LV J, DONG Y, GU Z, et al. Programmable DNA nanoflowers for biosensing, bioimaging, and therapeutics[J]. Chemistry, 2020, 26(64): 14512-14524.
13 YAN Y C, LI J, LI W H, et al. DNA flower-encapsulated horseradish peroxidase with enhanced biocatalytic activity synthesized by an isothermal one-pot method based on rolling circle amplification[J]. Nanoscale, 2018, 10(47): 22456-22465.
14 PAN M, JIANG Q Y, SUN J L, et al. Programming DNA nanoassembly for enhanced photodynamic therapy[J]. Angew Chem Int Ed Engl, 2020, 59(5): 1897-1905.
15 ZHANG K X, LIU J J, SONG Q L, et al. DNA nanosponge for adsorption and clearance of intracellular miR-21 and enhanced antitumor chemotherapy[J]. ACS Appl Mater Interfaces, 2019, 11(50): 46604-46613.
16 JING X M, YANG F M, SHAO C C, et al. Role of hypoxia in cancer therapy by regulating the tumor microenvironment[J]. Mol Cancer, 2019, 18(1): 157.
17 PARK J H, MOON M, KIM J S, et al. TOPK mediates hypoxia-induced epithelial-mesenchymal transition and the invasion of nonsmall-cell lung cancer cells via the HIF-1α/snail axis[J]. Biochem Biophys Res Commun, 2021, 534: 941-949.
18 FANG J, NAKAMURA H, MAEDA H. The EPR effect: unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect[J]. Adv Drug Deliv Rev, 2011, 63(3): 136-151.
19 KIM E, ZWI-DANTSIS L, REZNIKOV N, et al. One-pot synthesis of multiple protein-encapsulated DNA flowers and their application in intracellular protein delivery[J]. Adv Mater, 2017, 29(26): 10.1002/adma.201701086.
Options
Outlines

/

〈 〉